Leslie Holsinger
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Leslie Holsinger
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 18 | |
Virobay, Inc.
 Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA.
13
| Extinct | Pharmaceuticals: Major | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Leslie Holsinger
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Become, Inc.
 Become, Inc. Internet Software/ServicesTechnology Services Become, Inc. operates search engine and comparison shopping service. The firm provides research information such as buying guides, product reviews, articles, forums, and other useful shopping information. It helps people make better buying decisions and purchases online. The company was founded by Michael Yang and Yeogirl Yun in 2004 and is headquartered in Santa Monica, CA. | Internet Software/Services | Director of Finance/CFO | |
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| REBUS HOLDINGS, INC. | Biotechnology | Chief Executive Officer | |
| University of California, Los Angeles | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| Georgetown University | College/University | Director/Board Member Graduate Degree | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Sheffield | College/University | Doctorate Degree | |
Dow Chemical Canada ULC
 Dow Chemical Canada ULC Chemicals: SpecialtyProcess Industries Dow Chemical Canada, Inc. manufactures chemicals and plastics products. It manufactures basic chemicals and plastics. The company's other products are ethylene glycol, polystyrene, and polyurethane resins. Dow Chemical Canada was founded in 1970 and is located in Calgary, Canada. | Chemicals: Specialty | Chief Tech/Sci/R&D Officer | |
Deloitte & Touche
 Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Stanford Health Care
 Stanford Health Care Hospital/Nursing ManagementHealth Services Stanford Health Care provides healthcare services. It services includes cardiac care, cancer treatment, neurosciences, surgery and organ transplants. The company was founded in 1956 and is headquartered in Stanford, CA. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Alzheimers Drug Discovery Foundation
 Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Biotechnology | Corporate Officer/Principal | |
| BIOASIS TECHNOLOGIES INC. | Biotechnology | Corporate Secretary | |
| FORTY SEVEN, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| DIADEXUS, INC. | Biotechnology | Director of Finance/CFO | |
Pacific Pharmaceutical Services LLC
 Pacific Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services Pacific Pharmaceutical Services LLC provides virtual pharmaceutical development and warehousing services. The company is based in Reno, NV. | Miscellaneous Commercial Services | Director/Board Member | |
| St Bartholomew's Hospital Medical College | College/University | Doctorate Degree Undergraduate Degree | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| Glialogix, Inc. | Director/Board Member Director/Board Member | ||
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
TPG Biotech
 TPG Biotech Investment ManagersFinance TPG Biotech (TPG biotech) is a venture capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2002. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Career Closet, Inc.
 Career Closet, Inc. Personnel ServicesCommercial Services Career Closet, Inc. provides vocational counseling services. The private company is based in Smyrna, GA. | Personnel Services | Director/Board Member | |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology CuraSen Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda in 2018 and is headquartered in San Mateo, CA. | Biotechnology | Founder Director/Board Member | |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Pharmaceuticals: Major | Founder Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| Innventure Management Services LLC | Investment Managers | Director/Board Member | |
| VINCERX PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nusano, Inc.
 Nusano, Inc. Medical SpecialtiesHealth Technology Nusano, Inc. is a privately held medical technology company that is committed to bringing stability and innovation to the medical radioisotopes market. The company is based in Valencia, CA. The company's proprietary ion source is smaller and more efficient than existing production methods, which allows for the simultaneous manufacturing of multiple radioisotopes. Nusano's state-of-the-art production facility will open in the first quarter of 2025. The company's technologies will supply the fight against cancer and support diagnostic and therapeutic radiopharmaceutical development. Christopher P. Lowe has been the CEO of the company since 2022. | Medical Specialties | Chief Executive Officer | |
| Sonoma Bioventures | Founder | ||
Lighthouse Pharmaceuticals, Inc.
 Lighthouse Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Lighthouse Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that specializes in precision medicine approaches to address major unmet medical needs. The private company is based in San Francisco, CA. The company's expertise lies in small molecule protease inhibition. Lighthouse's lead program, LHP588, is a phase 2b ready orally bioavailable small molecule that targets a specific infectious pathogen, Porphyromonas gingivalis. This pathogen is associated with chronic degenerative and inflammatory disorders such as dementia, periodontal disease, atherosclerosis, and orodigestive cancers. Lighthouse Pharmaceuticals was founded in 2022 by Casey Crawford Lynch, who has been the CEO since 2022. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 46 |
| Vereinigtes Königreich | 3 |
| Kanada | 2 |
| Taiwan | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Technology Services | 3 |
| Process Industries | 3 |
Operativ
| Director/Board Member | 179 |
| Corporate Officer/Principal | 94 |
| Independent Dir/Board Member | 49 |
| Chief Tech/Sci/R&D Officer | 36 |
| Founder | 28 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Daniel Janney | 47 |
| Una Ryan | 38 |
| Heather Elizabeth Preston | 34 |
| Jeff Bird | 30 |
| Karen Smith | 29 |
| Christopher Lowe | 25 |
| Robert Booth | 22 |
| Thomas Dietz | 21 |
| Robert Emanuele | 16 |
| Dirk Thye | 13 |
| James Welch | 12 |
| Michael J. Detke | 12 |
| David Karpf | 11 |
| Casey Lynch | 11 |
| Philip Low | 10 |
- Börse
- Insiders
- Leslie Holsinger
- Unternehmensverbindungen
